Profund Advisors LLC Kura Oncology, Inc. Transaction History
Profund Advisors LLC
- $2.97 Billion
- Q3 2025
A detailed history of Profund Advisors LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 24,835 shares of KURA stock, worth $278,152. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,835
Previous 22,357
11.08%
Holding current value
$278,152
Previous $128,000
71.09%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
213Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...